Incorporating the Central Vein Sign Into the Diagnostic Criteria for Multiple Sclerosis

Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis

(2022) Lynn Daboul et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Central vein sign: a diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial

(2021) D. Ontaneda et al.   NeuroImage-Clinical

The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis

(2020) Marco Castellaro et al.   Diagnostics

Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers

(2019) Marwa Kaisey et al.   Multiple Sclerosis and Related Disorders

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis

(2019) Tim Sinnecker et al.   JAMA Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter Lesions

(2018) J.D. Dworkin et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome

(2018) Roos M. van der Vuurst de Vries et al.   JAMA Neurology

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

(2016) Pascal Sati et al.   Nature Reviews Neurology

Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis

(2014) P Sati et al.   Multiple Sclerosis Journal